Core Viewpoint - Altria's stock has shown strong performance with a 16% increase in 2026 and a dividend yield of 6.4%, supported by its consistent dividend growth and strategic focus on nicotine products [1] Group 1: Stock Performance and Dividend - Altria's stock rose 16% in 2026, outperforming the broader market, and has increased 25% over the past year [1] - The stock offers a dividend yield of approximately 6.4% and is trading less than 2% below its 52-week high of $68.60 [1] - Altria has raised its dividend for 57 consecutive years, aiming to pay out about 80% of adjusted earnings per share as dividends [1] Group 2: Market Demand and Product Strategy - The demand for Altria's flagship Marlboro brand remains steady due to nicotine's addictive nature, allowing for price increases even amidst declining cigarette sales [1] - Traditional cigarette sales dropped about 10% in 2025, but Altria is shifting towards smoke-free products, with its on! oral nicotine pouches seeing a 10.9% increase in shipments [1] - Nicotine pouches now account for over 55% of the overall oral tobacco market, with expectations for continued growth through 2036 [1] Group 3: Regulatory Challenges - Altria faced regulatory issues that led to the withdrawal of its NJOY Ace e-vapor product from stores, with no expected return in 2026 [1] - The company is now focusing more on oral nicotine products in response to these challenges [1]

Core Viewpoint - PepsiCo is recognized as an elite dividend stock, having extended its dividend growth streak to 54 consecutive years, making it a member of the Dividend Kings group, which signifies companies that have increased their dividends for at least 50 years [2][11] Dividend Growth - PepsiCo's dividend yield is currently around 3.5%, significantly higher than the S&P 500's yield of 1.2%, making it an attractive option for passive income [2] - The company announced a 5% increase in its March dividend payment compared to the previous year and a 4% increase for the June payment, marking its 54th consecutive annual dividend increase [4] Financial Health - In the previous year, PepsiCo generated approximately $12.1 billion in operating cash flow, which comfortably covered its capital expenditures of $4.4 billion and dividend payments of $7.6 billion [5] - The company ended the year with about $9.5 billion in cash on its balance sheet, supporting its strong A+ credit rating [5] Future Cash Returns - PepsiCo anticipates returning $7.9 billion in dividends to investors in 2026, alongside a planned stock repurchase of $1 billion as part of a $10 billion repurchase program through early 2030 [7] Revenue and Earnings Growth - The company expects net revenue growth of 4% to 6% and organic revenue growth of 2% to 4% in 2026, which will support core earnings-per-share growth of 4% to 6% on a constant-current basis [8] - PepsiCo aims for long-term annual organic revenue growth of 4% to 6% and high single-digit earnings-per-share growth on a constant currency basis [9] Strategic Investments - The company is investing nearly 5% of its net revenue in 2026 to support growth, focusing on high-growth areas [9] - PepsiCo made strategic acquisitions, including the purchase of Poppi for $1.7 billion and increasing its stake in Celsius to 11% through a $585 million acquisition of convertible preferred stock [10]

With the S&P 500 trading near its all-time highs, investors might be reluctant to buy new stocks. But instead of shunning all stocks, it might be smarter to simply pivot toward defensive consumer staples stocks, which are more resistant to market downturns. Two such evergreen stocks are Coca-Cola (NYSE: KO) and Altria (NYSE: MO). Both companies are Dividend Kings, which have raised their payouts annually for at least half a century. Where to invest $1,000 right now? Our analyst team just revealed what the ...

LODI, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Farmers & Merchants Bancorp (OTCQX: FMCB) (the “Company” or “FMCB”), the parent company of Farmers & Merchants Bank of Central California (the “Bank” or “F&M Bank”), declared a quarterly cash dividend of $5.10 per share, up from $5.05 for the previous quarter which was paid on January 2, 2026. The cash dividend is payable on April 1, 2026, to shareholders of record on March 11, 2026. The cash dividends for 2025 totaled $19.35 per share, up 6.9% compared to the ...

Get The Whole Dividend Kings StoryClick here to subscribe to The Dividend Dogcatcher. Get more information and the follow-up to this article.Catch A Dog On Facebook at 9:45AM ET every NYSE trade day on Facebook/Dividend Dog Catcher, a Fredrik Arnold live video highlights a portfolio candidate in the Underdog Daily Dividend Show!Root for the Underdog. Comment below all on your favorite, least favorite, or curiosity stock tickers to make them eligible for inclusion in future FA follower reports. ...

Consistency rarely makes the headlines, but I say it's what separates the best companies from the rest. When I look for that kind of consistency in the market, dividend growth is often a good place to start. Some dividend stocks don’t need big narratives or high yields to stand out; they simply keep doing the right things and let the results compound over time. More News from Barchart Dividend Kings are the perfect example of consistency- but that’s not all they offer. They're often viewed as steady an ...

Group 1 - Becton Dickinson and Co is highlighted for its strong performance in the medical technology sector, showing resilience amid market fluctuations [1] - Stepan Company is noted for its growth in specialty chemicals, with a focus on sustainable practices and innovation driving its market position [1] - H2O America is recognized for its advancements in water treatment solutions, contributing to environmental sustainability and addressing water scarcity issues [1] Group 2 - The overall market analysis indicates a trend towards increased investment in healthcare and environmental sectors, reflecting changing consumer preferences and regulatory pressures [1] - Companies are adapting to market demands by enhancing their product offerings and focusing on sustainability, which is becoming a key differentiator in competitive landscapes [1] - The analysis suggests that ongoing technological advancements will continue to shape the future of these industries, presenting both opportunities and challenges for investors [1]

Core Insights - PepsiCo offers a higher dividend yield of 3.8% compared to Coca-Cola's 2.8%, and has increased its dividend by 39% since 2021, while Coca-Cola's growth is at 21% [1] - However, Coca-Cola outperforms PepsiCo in earnings growth, profit margins, and perceived dividend safety, making it a more attractive investment [2] Earnings Growth - Coca-Cola reported adjusted earnings growth of 30% last quarter, while PepsiCo experienced an 11% decline in adjusted earnings [2] - Over the past year, Coca-Cola's adjusted earnings growth has been nearly double digits, contrasting with PepsiCo's significant shrinkage [3] Profit Margins - Coca-Cola's profit margin stands at 27.3%, significantly higher than the industry average of 13.4% and PepsiCo's 7.8% [4] - Coca-Cola's profit margin has been increasing, while PepsiCo's has been declining, indicating better pricing power and operational efficiency for Coca-Cola [4] Dividend Safety - Both companies are classified as Dividend Kings, but Coca-Cola's dividend is perceived as safer due to its stronger financial performance [5]

Core Viewpoint - Consumer staples stocks, particularly those that are currently undervalued, present a significant buying opportunity for value investors, especially in light of their underperformance compared to the broader market [1][2]. Group 1: Procter & Gamble (P&G) - P&G experienced a challenging 2025, with a stock value decline of 14.5%, reaching a near three-year low [4]. - The company reported a 1% decline in sales volume and flat organic sales growth, leading to a 5% drop in diluted net earnings per share (EPS) [5]. - P&G has adjusted its fiscal 2026 diluted net EPS growth forecast to a range of 1% to 6%, down from a previous estimate of 3% to 9% [5]. - The company is under new leadership and aims to enhance its value proposition by focusing on volume growth rather than price increases [8]. - P&G boasts a strong dividend yield of 2.9% and has increased its dividend for 69 consecutive years, making it an attractive option for income investors [9][11]. Group 2: Kimberly-Clark - Kimberly-Clark reported a modest 3.2% growth in adjusted EPS and flat adjusted operating profit, with a 1.7% increase in organic sales [12]. - The company is in a downturn but plans to acquire Kenvue to diversify its product offerings, which is expected to enhance its market position [13]. - Kimberly-Clark anticipates achieving $2.1 billion in annual cost synergies from the acquisition within three years [15]. - The company has a dividend yield of 5% and has increased its dividend for 54 consecutive years, making it appealing for value investors [17][19]. Group 3: Comparative Analysis - P&G is considered a higher quality company with a strong brand portfolio and better diversification, while Kimberly-Clark offers a cheaper valuation and higher yield, making it a potential turnaround play [20]. - Both companies are currently facing growth challenges due to a slowdown in consumer spending but continue to generate substantial free cash flow and earnings to support their dividends [20]. - A balanced investment strategy could involve a 50/50 split between both stocks, yielding an average of 4% [21].

Core Viewpoint - The article emphasizes the importance of dividend stocks as a reliable investment option, particularly during varying market conditions, highlighting three companies known as Dividend Kings that are recommended for long-term investment. Group 1: Dividend Kings Overview - Dividend Kings are companies that have increased their dividends for at least 50 consecutive years, indicating a strong commitment to returning value to shareholders [3]. - These companies provide passive income and can offer stability during market downturns while also benefiting from market upswings [2]. Group 2: Abbott Laboratories - Abbott Laboratories has a dividend of $2.52, yielding 2.4%, which is higher than the S&P 500's 1.1% yield [4]. - The company has a diversified healthcare business with four units: medical devices, diagnostics, nutrition, and established pharmaceuticals, providing security against downturns in any single unit [6]. Group 3: Target - Target has faced challenges recently, including a shift in consumer behavior and theft, but is implementing strategies to recover, such as creating an enterprise acceleration office [7][8]. - The company offers a dividend of $4.56, yielding 4.5%, which can provide passive income while the stock potentially rebounds [10]. Group 4: Johnson & Johnson - Johnson & Johnson spun off its consumer health business to focus on higher-growth areas, resulting in a 6% sales increase to over $94 billion last year and an 8% rise in adjusted diluted earnings per share [11][12]. - The company pays a dividend of $5.20, yielding 2.3%, making it a solid choice for passive income [14].